Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

12+ years of clinical experience in university hospitals in Germany and Spain.
International education: Ukraine – Germany – Spain.
Member of the German Society of Surgeons (BDC).
Certified in radiological diagnostics and robotic surgery.
Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.

How to use ARGENPAL 42.5 mg CUTANEOUS BAR

Introduction

Package Leaflet: Information for the User

ARGENPAL 42.5 mg skin stick

Silver nitrate

Read all of this leaflet carefully before you start using this medicine

Keep this leaflet, you may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
If you experience any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the package leaflet:

What is Argenpal and what is it used for
What you need to know before you use Argenpal
How to use Argenpal
Possible side effects
Storage of Argenpal

Contents of the pack and further information

1. What is Argenpal and what is it used for

Argenpal belongs to a group of medicines called antiseptics and disinfectants. It is used in the following cases:

Treatment of warts and granulomas (inflammatory nodules) of the skin,
Treatment of mouth ulcers (aphthous ulcers),
Treatment of nasal bleeding originating from the anterior part of the nasal septum (anterior epistaxis).

2. What you need to know before you use Argenpal

Do not use Argenpal:

If you are allergic (hypersensitive) to silver nitrate or any of the other components of this medicine (listed in section 6).
If you have wounded, infected, irritated, or reddened skin,
If you have moles, birthmarks, or other skin spots, genital warts, facial warts, or mucosal warts. Healthcare personnel will not apply Argenpal to the anogenital area or to extensive areas.

Warnings and precautions

Silver nitrate is a corrosive substance that should only be applied to the damaged area to be treated, avoiding unnecessary stains on the skin.

Treatment with silver nitrate produces a black stain on the skin that disappears over time. Healthcare personnel will not repeatedly apply silver nitrate to the same spot, as the stain may become permanent.

In the treatment of nasal bleeding (anterior epistaxis), healthcare personnel will be careful not to apply the medicine to the same place on both sides of the nasal septum, to avoid possible perforation of the septum.

If any problems occur, administration will be interrupted.

Other medicines and Argenpal

Tell your doctor or pharmacist if you are using or have recently used any other medicines.

It should not be used in conjunction with other medicines in the same area.

Pregnancy, breastfeeding, and fertility

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Your doctor will assess the risk-benefit ratio of using Argenpal, as the efficacy and safety of using silver nitrate in pregnant women are unknown and may affect reproductive capacity.

Driving and using machines

There is no evidence of effects on the ability to drive vehicles or use machines.

3. How to use Argenpal

Argenpal should be administered by a healthcare professional, on the skin (cutaneous use).

Each Argenpal skin stick is for single use and application.

With the Argenpal skin stick previously moistened in water for a few seconds, the area to be treated should be brushed for a few seconds, trying to limit its application to the affected area, to avoid the appearance of unnecessary black stains on the skin.

It is recommended to protect the surrounding healthy skin with an oily ointment or cream, such as petroleum jelly.

Finally, the treated area should be covered with a bandage or similar.

The application should be performed exclusively by the doctor and for a brief period, which will depend on the degree of action desired.

If you use more Argenpal than you should

Due to its application on the skin, Argenpal sticks are not toxic if used properly, as silver nitrate is normally not absorbed. In case of occurrence, silver nitrate poisoning can be acute or chronic.

Chronic silver nitrate poisoning develops slowly and is due to the continued absorption and penetration of silver compounds into the mucous membranes. It is characterized by the appearance of a bluish-gray skin discoloration (argyria).

Accidental or intentional ingestion of silver nitrate can cause throat and stomach pain, acute gastroenteritis, nausea, vomiting, diarrhea, dizziness, weak and rapid pulse, shallow breathing, and convulsions.

For the treatment of poisoning, your doctor will use sodium chloride, followed by stomach lavage or emetic medications (which induce vomiting) or milk or other demulcents (substances that mimic the protective action of mucous membranes) in abundance. For pain and nervous irritability, pentobarbital sodium (a hypnotic) will be administered at a dose of 0.2 g intravenously, and if necessary, cardiotonics (medications that increase heart rate) will be used, and artificial respiration will be applied to maintain vital signs.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount ingested.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

The following side effects have been observed:

Disorders of the skin and subcutaneous tissue:

Frequent (may affect up to 1 in 10 people):

Argenpal may be irritating, causing skin inflammation (dermatitis), redness, burns, skin discoloration, or bluish-gray skin discoloration (argyria) that disappears over time. After prolonged exposure, skin discoloration or stains may become permanent.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Argenpal

Keep out of the sight and reach of children.

No special storage conditions are required. Store in the original packaging.

Do not use Argenpal after the expiry date stated on the packaging. The expiry date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE Circular symbol with a black cross in the center and a curved arrow indicating clockwise rotation collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Contents of the pack and further information

Composition of Argenpal

The active ingredient is silver nitrate. Each skin stick contains 42.5 mg of silver nitrate.

The other ingredients are: potassium nitrate.

Appearance of the product and packaging contents

Skin stick.

Plastic rod approximately 2.4 mm in diameter and 9.5 cm in length with a product head at the end, white or grayish-white in color.

It is presented in a topaz-colored plastic tube containing 10 skin sticks.

Marketing authorization holder and manufacturer

Marketing authorization holder

Braun Medical, S.A.

Ctra. de Terrassa, 121

08191-Rubí (Barcelona)

Spain

Manufacturer

Braun Medical, S.A.

Ronda de los Olivares, Parcela II, Poligono Industrial Los Olivares

23009-Jaén

This leaflet was approved in February 2015

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.es.

ARGENPAL 42.5 mg CUTANEOUS BAR

Jonathan Marshall Ben Ami

Yevgen Yakovenko

Jonathan Marshall Ben Ami

Yevgen Yakovenko